Michael Schicker, DO
Sports Medicine · Ponderay, IDNPI 1861774291
Payments from drug & device makers
What this record shows
This record is dominated by education: $2,543 of the $4,072 with a category attached, or 62.4%. Arthrex accounts for 68.6% of it on its own, with 15 other manufacturers making up the rest. Reporting peaked in 2022 at $3,289 and has fallen 99.2% since, to $26 in 2025.
Across 42 payments — averaging $96.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$3K
- Summit Surgical Corp.$407
- Zimmer Biomet$381
- Stryker$150
- Vericel Corporation$99
- Sawtooth Surgical Solutions Inc$53
- plus $188 from 10 others
What the payments were for
- Travel & lodging$45811%
- Food & beverage$1,07126%
- Education$2,54362%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 10 | $2,795 |
| Summit Surgical Corp. | 4 | $407 |
| Zimmer Biomet | 4 | $381 |
| Stryker | 7 | $150 |
| Vericel Corporation | 3 | $99 |
| Sawtooth Surgical Solutions Inc | 1 | $53 |
| Boehringer Ingelheim | 2 | $35 |
| Amgen | 2 | $30 |
| Gilead | 2 | $27 |
| Pacira Therapeutics, Inc. | 1 | $22 |
| GSK | 1 | $14 |
| Avanos Medical | 1 | $14 |
| Phadia US Inc. | 1 | $13 |
| Novo Nordisk | 1 | $13 |
| Otsuka America Pharmaceutical, Inc. | 1 | $13 |
| Quidel Corporation | 1 | $7 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,072 in reported general payments places this provider in the 75th percentile of 33 sports medicine providers in Idaho.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 139 | $1,063 |
| Meloxicam | 174 | $620 |
| Oxycodone Hcl | 61 | $336 |
| Tranexamic Acid | 36 | $327 |
| Scopolamine | 12 | $146 |
| Gabapentin | 58 | $106 |
| Tramadol Hcl | 32 | $75 |
| Amoxicillin | 24 | $14 |
Paid to pharmacies, not to this prescriber.
Other sports medicine in Ponderay
- Nathan GrimmBoise$23K
- Aaron NewtonNampa$18K
- John JelinekLewiston$13K
- Michael GustavelBoise$12K
- Arvin AlexanderKetchum$10K
- Jennifer MillerBoise$9K
- Richard RadnovichBoise$4K
- Richard WathnePocatello$4K
- Christopher DewingPost Falls$3K
- Darin JurgensmeierBoise$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.